# Clozapine and Olanzapine Treatment of Aggression

> **NCT01123408** · NA · COMPLETED · sponsor: **Nathan Kline Institute for Psychiatric Research** · enrollment: 110 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Clozapine
- **DRUG:** Olanzapine
- **DRUG:** Haloperidol

## Key facts

- **NCT ID:** NCT01123408
- **Lead sponsor:** Nathan Kline Institute for Psychiatric Research
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-06
- **Primary completion:** 2004-07
- **Final completion:** 2004-07
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2010-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01123408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01123408, "Clozapine and Olanzapine Treatment of Aggression". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01123408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*